Please ensure Javascript is enabled for purposes of website accessibility

Why Covetrus Stock Plunged 40% Today

By Joe Tenebruso - Aug 13, 2019 at 8:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The veterinary technology platform provider's Q2 earnings and forward guidance had investors running for the exits.

What happened

Shares of Covetrus (CVET 11.60%) lost 40% of their value on Tuesday, following the release of the company's second-quarter results. 

So what 

Covetrus' net sales fell 1% year over year $1 billion. That was below Wall Street's estimates for sales of $1.1 billion. 

The veterinary technology company also posted a net loss of $10 million, or $0.09 per share. Analysts had been expecting Covetrus to report earnings of $0.17 per share. 

"Q2 was impacted by challenges in North America and the UK," CEO Benjamin Shaw said during a conference call with analysts. "In the U.S. we saw moderating traffic in veterinary practices and declining sales of veterinary products purchased in distribution and resold to their clients."

Shaw went on to state that "unusual inventory activity in the UK related to Brexit" also weighed on Covetrus' second-quarter results.

A downwardly sloping line chart

Image source: Getty Images.

Now what

Worse still, Covetrus slashed its full-year guidance in part because of "end-market softness." Management now expects:

  • Low-single-digit pro forma (adjusted) organic net sales growth, down from a prior forecast of 3% to 5% growth.
  • Pro forma adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of at least $200 million, down from $235 million to $250 million.

"While we are disappointed in the revision to our 2019 outlook, we remain encouraged by the increased demand for our technology platform, which remains our strategic long-term driver of accelerated net sales growth and margin expansion," CFO Christine Komola said in a press release. "Longer-term, we are focused on driving additional efficiencies in our organization, executing against our stated value capture priorities, improving free cash flow, and deleveraging the balance sheet."

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Covetrus, Inc. Stock Quote
Covetrus, Inc.
CVET
$20.11 (11.60%) $2.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
331%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.